CA1269978A - Antibiotiques a base de carbapenemes - Google Patents

Antibiotiques a base de carbapenemes

Info

Publication number
CA1269978A
CA1269978A CA000436924A CA436924A CA1269978A CA 1269978 A CA1269978 A CA 1269978A CA 000436924 A CA000436924 A CA 000436924A CA 436924 A CA436924 A CA 436924A CA 1269978 A CA1269978 A CA 1269978A
Authority
CA
Canada
Prior art keywords
alkyl
carbon atoms
phenyl
group
atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000436924A
Other languages
English (en)
Inventor
Choung U. Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Application granted granted Critical
Publication of CA1269978A publication Critical patent/CA1269978A/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26Radicals substituted by sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/061,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65611Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. penicillins and analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
CA000436924A 1982-09-28 1983-09-16 Antibiotiques a base de carbapenemes Expired - Lifetime CA1269978A (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US42575582A 1982-09-28 1982-09-28
US425,755 1982-09-28
US53001183A 1983-09-09 1983-09-09
US530,011 1983-09-09

Publications (1)

Publication Number Publication Date
CA1269978A true CA1269978A (fr) 1990-06-05

Family

ID=27026797

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000436924A Expired - Lifetime CA1269978A (fr) 1982-09-28 1983-09-16 Antibiotiques a base de carbapenemes

Country Status (29)

Country Link
KR (1) KR890002228B1 (fr)
AR (1) AR241785A1 (fr)
AT (1) AT382621B (fr)
AU (1) AU575541B2 (fr)
CA (1) CA1269978A (fr)
CH (1) CH656130A5 (fr)
CS (1) CS247168B2 (fr)
DD (1) DD212255A5 (fr)
DE (1) DE3334937A1 (fr)
DK (1) DK442383A (fr)
ES (1) ES8503354A1 (fr)
FI (1) FI78094C (fr)
FR (1) FR2533568B1 (fr)
GB (1) GB2128187B (fr)
GR (1) GR78696B (fr)
HU (1) HU191066B (fr)
IE (1) IE55947B1 (fr)
IL (1) IL69824A (fr)
IT (1) IT1163944B (fr)
LU (1) LU85021A1 (fr)
NL (1) NL8303310A (fr)
NO (1) NO163284C (fr)
NZ (1) NZ205626A (fr)
OA (1) OA07548A (fr)
PT (1) PT77404B (fr)
SE (1) SE461734B (fr)
SU (1) SU1493108A3 (fr)
YU (1) YU43196B (fr)
ZW (1) ZW20783A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683296A (en) * 1983-03-07 1987-07-28 Bristol-Myers Company Carbapenem intermediates
CA1273012A (fr) * 1984-07-02 1990-08-21 Burton G. Christensen Carbapenems a substituant mono- ou bicyclique de type heteroarylalkythio 2-quaternaire, extrerieurement alkyle
CA1273011A (fr) * 1984-07-02 1990-08-21 Susan M. Schmitt Carbapenems a substituant mono- ou bicyclique de type heteroarylalkythio 2-quaternaire, exterieurement aklyle
US4680292A (en) * 1984-12-13 1987-07-14 Merck & Co., Inc. Carbapenems and 1-methylcarbapenems having a 2-heteroaryliumaliphatic substituent
US4725594A (en) * 1984-12-13 1988-02-16 Merck & Co., Inc. Carbapenems having an internally or externally alkylated mono- or bicyclic 2-quaternary heteroarylalxyl heteromethyl substituent
US4729993A (en) * 1984-12-13 1988-03-08 Merck & Co., Inc. Carbapenems and 1-methylcarbapenems having an externally alkylated mono- or bicyclic 2-quaternary heteroarylalkyl substituent
US4665169A (en) * 1985-09-11 1987-05-12 Bristol-Myers Company Carbapenem antibiotics
US4880922A (en) * 1985-11-22 1989-11-14 Bristol-Myers Company Carbapenems with quaternized heterothioalkylthio substitution at position 2
NZ219892A (en) * 1986-04-15 1991-02-26 Merck & Co Inc N-amino quaternised heteroarylium carbapenem derivatives and pharmaceutical compositions thereof
DK168047B1 (da) * 1987-12-07 1994-01-24 Lederle Japan Ltd (1r,5s,6s)-2-substitueret thio-6-oe(r)-1-hydroxyethylaa-1-methyl-carbapenem-3-carboxylsyrederivater, fremgangsmaade til remstilling deraf, midler og praeparater indeholdende den krystallinske forbindelse samt dens anvendelse.
US6174877B1 (en) 1996-01-12 2001-01-16 Takeda Chemical Industries, Ltd. Carbapenem compound, their production and use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0082133A3 (en) * 1979-04-19 1983-07-20 Merck & Co. Inc. A process for preparing intermediates useful for preparing 2-substituted-6-substituted-1-carbadethiapen-2-em-3-carboxylic acids
IE52147B1 (en) * 1980-03-27 1987-07-08 Merck & Co Inc 4-(3-carboxy-2-oxopropyl)-azetidin-2-ones and process for their preparation
EP0038869A1 (fr) * 1980-04-30 1981-11-04 Merck & Co. Inc. Procédé de préparation de 1-carbapénèmes et intermédiaires pour leur préparation
PT73791B (en) * 1980-10-17 1983-10-14 Merck & Co Inc Process for preparing 2-carbamimidoyl-6-substituted-1- -carbadethiapen-2-em-3-carboxylic acids
EP0050927B1 (fr) * 1980-10-25 1985-03-27 Beecham Group Plc La préparation de bêta-lactames antibiotiques
US4552873A (en) * 1981-08-19 1985-11-12 Sankyo Company Limited Carbapenem compounds, and compositions containing them
EP0074599A1 (fr) * 1981-09-09 1983-03-23 Takeda Chemical Industries, Ltd. Dérivés de 5,6-cis-carbapénème, leurs préparation et utilisation

Also Published As

Publication number Publication date
AU1934283A (en) 1984-04-05
NO163284B (no) 1990-01-22
KR840006249A (ko) 1984-11-22
GB2128187A (en) 1984-04-26
ES525983A0 (es) 1985-02-16
IL69824A0 (en) 1983-12-30
DE3334937C2 (fr) 1991-05-02
SE461734B (sv) 1990-03-19
DD212255A5 (de) 1984-08-08
OA07548A (fr) 1985-03-31
YU43196B (en) 1989-04-30
HU191066B (en) 1987-01-28
CS247168B2 (en) 1986-12-18
FR2533568B1 (fr) 1990-01-26
ZW20783A1 (en) 1984-11-28
DK442383D0 (da) 1983-09-27
NL8303310A (nl) 1984-04-16
PT77404B (en) 1986-06-26
SE8305217L (sv) 1984-03-29
SE8305217D0 (sv) 1983-09-27
ES8503354A1 (es) 1985-02-16
IL69824A (en) 1991-04-15
GR78696B (fr) 1984-09-27
IT1163944B (it) 1987-04-08
GB8325744D0 (en) 1983-10-26
AR241785A1 (es) 1992-12-30
SU1493108A3 (ru) 1989-07-07
IT8323022A0 (it) 1983-09-27
AT382621B (de) 1987-03-25
KR890002228B1 (ko) 1989-06-24
CH656130A5 (de) 1986-06-13
ATA344983A (de) 1986-08-15
DE3334937A1 (de) 1984-04-05
NZ205626A (en) 1986-12-05
PT77404A (en) 1983-10-01
NO163284C (no) 1990-05-02
GB2128187B (en) 1986-06-18
FI833417A0 (fi) 1983-09-23
IE832266L (en) 1984-03-28
YU190683A (en) 1985-10-31
DK442383A (da) 1984-03-29
FI833417A (fi) 1984-03-29
FR2533568A1 (fr) 1984-03-30
FI78094C (fi) 1989-06-12
FI78094B (fi) 1989-02-28
IE55947B1 (en) 1991-02-27
LU85021A1 (fr) 1984-04-24
NO833479L (no) 1984-03-29
AU575541B2 (en) 1988-08-04

Similar Documents

Publication Publication Date Title
CA1273009A (fr) Antibiotiques a base de carbapenemes
US4282236A (en) β-Lactam antibacterial agents, their use in pharmaceutical compositions, and intermediates
DE69020676T2 (de) Tricyclische Carbapenemverbindungen.
CA1269978A (fr) Antibiotiques a base de carbapenemes
DE69129175T2 (de) 1-Methylcarbapenemderivate und Verfahren zu ihrer Herstellung
CA2065079C (fr) Carbapenemes polycycliques; preparation et utilisation
US4032521A (en) Cephalosporin phosphonic acid, sulfonic acid and sulfonamide compounds
DE2356388A1 (de) Cephalosporine und verfahren zu ihrer herstellung
CA1283659C (fr) Carbapenems antibiotiques
CH669197A5 (de) Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutische mittel.
EP0055562B1 (fr) Dérivés de céphalosporines
CA1272719A (fr) Antibiotiques a base de carbapenemes
CA1273015A (fr) Carbapenemes substituees par des residus heterothioalkylthio quaternaires en position 2
DE3586591T2 (de) Antibiotisch wirkende isoxazolderivate, ihre herstellung und verwendung.
KR880001055B1 (ko) 카르바페넴 유도체의 제조방법
CH633800A5 (en) Process for the preparation of guanidines
US4150223A (en) Cephalosporin phosphonic acid, sulfonic acid and sulfonamide compounds
CA1273014A (fr) Procede de preparation de carbapenemes
CA1273010A (fr) Procede de preparation de carbapenemes
HU198491B (en) Process for producing carbapenem antibiotics
DE3587308T2 (de) Monobactame.
JPS6187682A (ja) カルバペネム抗生物質
DE2911787A1 (de) Cephalosporinderivate und ihre salze sowie verfahren zu ihrer herstellung
EP0018155A2 (fr) Composés de céphalosporine, procédé pour leur préparation, compositions pharmaceutiques les contenant et leur utilisation comme agents thérapeutiques contre un microorganisme
AT387574B (de) Verfahren zur herstellung neuer carbapenem-derivate

Legal Events

Date Code Title Description
MKLA Lapsed